Cerebral metabolic stimulant; shows antihypoxic effects. Vasodilator.
Product Details
| Alternative Name: | (3α,16α)-Eburnamenin-14(15H)-one, Vincamone, Vinburnine |
| |
| Formula: | C19H22N2O |
| |
| MW: | 294.4 |
| |
| CAS: | 4880-88-0 |
| |
| MI: | 14: 3487 |
| |
| RTECS: | YY8575570 |
| |
| Purity: | ≥99% (Assay) |
| |
| Appearance: | White to slightly yellow crystalline powder. |
| |
| Solubility: | Soluble in chloroform. |
| |
| Shipping: | Ambient |
| |
| Long Term Storage: | -20°C |
| |
| Regulatory Status: | RUO - Research Use Only |
| |
Please mouse over
Product Literature References
Asymmetric synthesis of (-)-eburnamonine and (+)-epi-eburnamonine from (4S)-4-ethyl-4-[2-(hydroxycarbonyl)ethyl]-2-butyrolactone: A.G. Wee & Q. Yu; J. Org. Chem.
66, 8935 (2001),
Abstract;
Experimental clinical studies on the effect of eburnamonine in cerebrovascular disorders: W. Jansen, et al.; Pharmacopsychiatry
19, 389 (1986),
Abstract;
’Cerebroactive’ drugs. Clinical pharmacology and therapeutic role in cerebrovascular disorders: A. Spagnoli & G. Tognoni; Drugs
26, 44 (1983), Review,
Abstract;
Experimental approach of activity and mechanism(s) of action of drugs used in cerebral metabolic insufficiency. Application to 1-eburnamonine: P. Linee, et al.; Eur. Neurol.
20, 253 (1981),
Abstract;
